Three-Dimensional-Cultured MSC-Derived Exosome-Hydrogel Hybrid Microneedle Array Patch for Spinal Cord Repair
- PMID: 35876503
- DOI: 10.1021/acs.nanolett.2c02259
Three-Dimensional-Cultured MSC-Derived Exosome-Hydrogel Hybrid Microneedle Array Patch for Spinal Cord Repair
Abstract
Exosomes derived from mesenchymal stem cells (MSCs) have been proven to exhibit great potentials in spinal cord injury (SCI) therapy. However, conventional two-dimensional (2D) culture will inevitably lead to the loss of stemness of MSCs, which substantially limits the therapeutic potency of MSCs exosomes (2D-Exo). Exosomes derived from three-dimensional culture (3D-Exo) possess higher therapeutic efficiency which have wide applications in spinal cord therapy. Typically, conventional exosome therapy that relies on local repeated injection results in secondary injury and low efficiency. It is urgent to develop a more reliable, convenient, and effective exosome delivery method to achieve constant in situ exosomes release. Herein, we proposed a controlled 3D-exohydrogel hybrid microneedle array patch to achieve SCI repair in situ. Our studies suggested that MSCs with 3D-culturing could maintain their stemness, and consequently, 3D-Exo effectively reduced SCI-induced inflammation and glial scarring. Thus, it is a promising therapeutic strategy for the treatment of SCI.
Keywords: exosomes; mesenchymal stem cell; microneedle; spinal cord injury; three-dimensional culture.
Similar articles
-
Transplantation of Human Mesenchymal Stem-Cell-Derived Exosomes Immobilized in an Adhesive Hydrogel for Effective Treatment of Spinal Cord Injury.Nano Lett. 2020 Jun 10;20(6):4298-4305. doi: 10.1021/acs.nanolett.0c00929. Epub 2020 May 13. Nano Lett. 2020. PMID: 32379461
-
Gelatin methacryloyl microneedle loaded with 3D-MSC-Exosomes for the protection of ischemia-reperfusion.Int J Biol Macromol. 2024 Aug;275(Pt 1):133336. doi: 10.1016/j.ijbiomac.2024.133336. Epub 2024 Jun 25. Int J Biol Macromol. 2024. PMID: 38936568
-
Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury.Stem Cell Res Ther. 2021 Feb 3;12(1):102. doi: 10.1186/s13287-021-02153-8. Stem Cell Res Ther. 2021. PMID: 33536064 Free PMC article. Review.
-
Bone mesenchymal stem cell-derived exosome-loaded injectable hydrogel for minimally invasive treatment of spinal cord injury.Nanomedicine (Lond). 2021 Aug;16(18):1567-1579. doi: 10.2217/nnm-2021-0025. Epub 2021 Jun 30. Nanomedicine (Lond). 2021. PMID: 34189939
-
Rewiring the Spine-Cutting-Edge Stem Cell Therapies for Spinal Cord Repair.Int J Mol Sci. 2025 May 23;26(11):5048. doi: 10.3390/ijms26115048. Int J Mol Sci. 2025. PMID: 40507858 Free PMC article. Review.
Cited by
-
Harnessing stem cell-derived exosomes: a promising cell-free approach for spinal cord injury.Stem Cell Res Ther. 2025 Apr 17;16(1):182. doi: 10.1186/s13287-025-04296-4. Stem Cell Res Ther. 2025. PMID: 40247394 Free PMC article. Review.
-
Inhibition of FOXD3 O-GlcNAc Modification Ameliorates Spinal Cord Injury by Promoting STUB1-Mediated Ubiquitination Degradation of HMGB1.Mol Neurobiol. 2025 Apr 24. doi: 10.1007/s12035-025-04954-x. Online ahead of print. Mol Neurobiol. 2025. PMID: 40272767
-
Clinical Translation Challenges and Strategies for Tumour Vaccines Considering Multiple Delivery Routes.Vaccines (Basel). 2025 Apr 27;13(5):469. doi: 10.3390/vaccines13050469. Vaccines (Basel). 2025. PMID: 40432082 Free PMC article. Review.
-
Exploring the role of polymers to overcome ongoing challenges in the field of extracellular vesicles.J Extracell Vesicles. 2023 Dec;12(12):e12386. doi: 10.1002/jev2.12386. J Extracell Vesicles. 2023. PMID: 38050832 Free PMC article. Review.
-
Advances and clinical challenges of mesenchymal stem cell therapy.Front Immunol. 2024 Jul 19;15:1421854. doi: 10.3389/fimmu.2024.1421854. eCollection 2024. Front Immunol. 2024. PMID: 39100671 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical